Article
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
15 Aug 2008
Abstract excerpt
The past decade has shown a marked increase in the use of high-throughput assays in clinical research into human cancer, including acute myeloid leukemia (AML). In particular, genome-wide gene expression profiling (GEP) using DNA microarrays has been extensively used for improved understanding of the diagnosis, prognosis, and pathobiology of this heterogeneous disease. This review discusses the progress that has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
